Skip to main content
SpringerLink
Log in

Kolorektales Karzinom

  • Chapter
Kompendium Internistische Onkologie

Zusammenfassung

Häufigkeit: Karzinome des Kolons und des Rektums gehören zu den häufigsten Tumoren überhaupt; ihr Anteil an den Karzinomerkrankungen weltweit beträgt ca. 9% (European Cancer News 1994) und steht damit nach dem Lungen-, Magen- und Mammakarzinom an 4. Stelle der jährlichen Krebsneuerkrankungen überhaupt. Die Mortalitätsstatistik in der alten BRD weist für das Jahr 1988 23962 an einem kolorektalen Karzinom verstorbene Patienten aus; da die Heilungsrate ca. 50% beträgt, kann von ca. 55000–60000 Neuerkrankungen pro Jahr in Gesamtdeutschland ausgegangen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Buroker TR, O’Connell MJ, Wieand HS, Krook JE, Gerstner JB, Mailliard JA (1994) Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12: 14–20

    PubMed  CAS  Google Scholar 

  • Bugat R, Riugier P, Douillard JY et al. (1995) Efficacy of irinothecan HCI (CPT 11) in patients with metastatic colorectal cancer after progression while receiving a 5-FU-based chemotherapie. Proc Am Soc Clin Oncol 14 (abstract 567)

    Google Scholar 

  • De Gramont J, Vignoud AJ, Tournigand T, Louvet C, Varette C, Raymond E, Krulik M (1995) Oxaliplatin with high-dose folinic acid in 5-fluorouracil 48-hour infusion in pretreated metastatic colorectal cancer. Eur J Cancer 31 A [Supp15]: 149–150

    Google Scholar 

  • Doci R, Gennari L, Bignami P et al. (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78: 797–801

    Article  PubMed  CAS  Google Scholar 

  • Drummond JT, Li GM, Longley MJ, Modrich P (1995) Isolation of an hMSH2p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268: 1909–1912

    Article  PubMed  CAS  Google Scholar 

  • Elias D, Lasser P, Rougier P et al. (1992) Nouvel echec dans la tentative de definition des indications d’exerese des metastases hepatiques d’origine colo-rectales. J Chir (Paris) 4: 1–25

    Google Scholar 

  • European Cancer News (1994) 7,9/10:15–20

    Google Scholar 

  • Font A, Abad A, Moreno I et al. (1994) Prognostic impact of K-ras mutations in resected colorectal cancer. Proc Eur Soc Med Oncol (Lissabon)

    Google Scholar 

  • Garufi C, Brienza S, Bensmaine MA et al. (1995) Addition of oxaliplatin (L-OHP) to chronomodulated (CM) 5-fluorouracil (5-FU) and folinic acid (FA) for reversal of acquired chemoresistance in patients with advanced colorectal cancer (ACC). Proc Am Soc Clin Oncol 14 (abstract 446)

    Google Scholar 

  • Gastrointestinal Tumor Study Group (1956) Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315: 1294

    Google Scholar 

  • Gastrointestinal Tumor Study Group (1992) Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10: 549

    Google Scholar 

  • Haller DG, Catalano PJ, Macdonald JS, Mayer RJ (1996) Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: preliminary results. Proc Am Soc Clin Oncol 15: 486

    Google Scholar 

  • Hamilton SR, Liu B, Parsons RE et al. (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332: 839–847

    Article  PubMed  CAS  Google Scholar 

  • Howe GR, Benito E, Castelleto R et al. (1992) Dietary intake of fiber and decreased risk of cancers of the colon and rectum: Evidence from the combined analysis of 13 case control studies. J Natl Cancer Inst 84: 1887–1896

    Article  PubMed  CAS  Google Scholar 

  • Hughes K, Simon R, Songhorabodi S et al. (1986) Resection of the liver for colorectal carcinoma metastases: A multiinstitutional study of patterns of recurrence. Surgery 100 (2): 278–284

    PubMed  CAS  Google Scholar 

  • Iino H, Fukayama M, Maeda Y et al. (1994) Molecular genetics for clinical management of colorectal carcinoma–17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with metastatic potential. Cancer 73: 1324–1330

    Article  PubMed  CAS  Google Scholar 

  • Jen J, Kim H, Piantadosi S et al. (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213–221

    Article  PubMed  CAS  Google Scholar 

  • Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L (1995) Thymidilate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumor. Cancer Res 55: 1407–1412

    PubMed  CAS  Google Scholar 

  • Köhne C-H, Schöffski P, Schmoll H-J (1994) Adjuvant therapy for colon adenocarcinoma: Current status of clinical investigation. Ann Oncol [Supp13]: 97–104

    Google Scholar 

  • Konsensus (1994) der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon-und Rektumkarzinom vom 11.3. 1994. Onkologie 17: 291–293

    Article  Google Scholar 

  • Kramer BS (ed) (1995) Hereditary breast and colon cancer. J Natl Cancer Inst, Bethesda/MD (Monographs, Vol 17, pp 1–124

    Google Scholar 

  • Lévi F, Misset, J-L, Brienza S (1992) A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 68: 893–901

    Article  Google Scholar 

  • Levin B (1995) The role of dietary factors and chemoprevention in gastrointestinal malignancy. Curr Opin Oncol 7: 377–380

    Article  PubMed  CAS  Google Scholar 

  • Mamounas EP, Rockette H, Jones J, Wieand S, Wickerham DL, Fisher B, Wolmark N (1996) Comparative efficacy of adjuvant chemotherapy in patients with Dukes B vs Dukes C colon cancer. Results from four NSABP adjuvant studies (C-01, C-02, C-03, C-04). Proc Am Soc Clin Oncol 15: 461

    Google Scholar 

  • Miller BA, Gloeckler LA, Hankaiy WF, Kosary CL, Edwards BK (eds) (1992) Cancer statistics review 1973–1989. US Department of Health and Human Services, Bethesda/MD

    Google Scholar 

  • Moertel CG, Fleming TR, MacDonald JS et al. (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352–358

    Article  PubMed  CAS  Google Scholar 

  • Moertel CG, Fleming T, MacDonald J, Haller D, Laurie J (1993) The Intergroup study of fluorouracil (5-FU) plus levamisole ( LEV) and levamisole alone as adjuvant therapy for stage C colon cancer. Proc Am Soc Clin Oncol 11: 161

    Google Scholar 

  • Moertel CG, Fleming TR, MacDonald JS et al. (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122: 321–326

    Article  PubMed  CAS  Google Scholar 

  • Negrier E, Avanzo B, Tavani A (1994) The role of vegetables and fruit in cancer risk. In: Hill MJ et al. (eds) Epidemiology of diet and cancer. Ellis Horwood, Chichester, pp 328–334

    Google Scholar 

  • Nogué M, Asegai M, Batiste G, Arcusa A, Moleda M, Anton E, Seigi E (1996) Phase-II-study of oral tegafur (TF) and low-dose oral leucovorin (LV) in advanced colorectal cancer ( ACC ). Proc Am Soc Clin Oncol 15: 443

    Google Scholar 

  • Nordlinger B, Guiguet M, Weiland JC, Balladur P, Boudjema B, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastasis to the liver. Cancer 77: 1254–1262

    Article  PubMed  CAS  Google Scholar 

  • O’Connell MJ (1989) A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer: A Mayo Clinic/North Central Cancer Treatment Group Study. Cancer 63: 1026–1030

    Article  PubMed  Google Scholar 

  • O’Connell MJ, Schaid DJ, Ganju V, Cunningham J, Kovach JS, Thibodeau SN (1992) Current status of adjuvant chemotherapy for colorectal cancer. Cancer 70: 1732–1739

    Article  PubMed  Google Scholar 

  • O’Connell MJ, Martenson JA, Wieand HS, Krook JE, MacDonald JS (1994) Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502–507

    Article  PubMed  Google Scholar 

  • O’Connell MJ, Laurie JA, Shepard L (1996) A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high-risk colon cancer: A collaborative trial of the National Cancer Institute Group and the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 15: 478

    Google Scholar 

  • Ooijen B van, Wiggers T, Meijer S et al. (1992) Hepatic resection of colorectal metastases in the Netherlands: A multiinstitutional 10-year study. Cancer 70 (1): 29–34

    Google Scholar 

  • Petrelli N, Douglass HO, Herrera L et al. (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal cancer: A prospective randomized phase III trial. J Clin Oncol 10: 1419–1426

    Google Scholar 

  • Piedbois P, Buyse M, Blijhman G, Glimelius B, Herrmann R, Valone F (1994) Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12: 960–969

    Google Scholar 

  • Poon MA, O’Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK, Levitt R, Kardinal CG, Mailliard JA (1991) Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9: 1967–1972

    PubMed  CAS  Google Scholar 

  • Riethmüller G, Schneider-Gädicke E, Schlimok et al., and the German Cancer Adj 17–1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet 342: 1177–1183

    Google Scholar 

  • Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D (1994) Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306: 752–755

    Article  Google Scholar 

  • Schmoll H-J (1994 a) Colorectal carcinoma: Current problems and future perspectives. Ann Oncol 5: 115–121

    Google Scholar 

  • Schmoll H-J (1994b) Adjuvante Chemotherapie beim Rektumkarzinom. Chirurg 65: 576–584

    PubMed  CAS  Google Scholar 

  • Schmoll H-J (1994 c) Zur Therapie kolorektaler Karzinome mit einer Kombination aus 5-Fluorouracil und Folinsäure. Dtsch Ärzteblatt 36:2345–2347

    Google Scholar 

  • Seitz JF, Cummingham-Urat D, Olvar IN et al. (1996) Final results and survival data of a large randomized trial of tomudex in advanced colorectal cancer (ACC) confirmed comparable efficacy to 5-fluorouracil plus leucovorin (5-FU + LV). Proc Am Soc Clin Oncol 15: 446

    Google Scholar 

  • Sun X-F, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Norenskjodd B (1992) Prognostik significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369–1373

    Article  PubMed  CAS  Google Scholar 

  • Toribara NW, Sleisinger MH (1995) Screening for colorectal cancer. N Engl J Med 332: 861–867

    Article  PubMed  CAS  Google Scholar 

  • Vermorken JB, Claessen AME, Gall HE et al. (1996) Randomized phase-III-trial of active specific immunotherapie (ASI) versus control in patients with Dukes B2, B3 or C colon cancer. Proc Am Soc Clin Oncol 15: 444

    Google Scholar 

  • Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Patel U, Ghosh L, Chen H-C, Banerjee (1993) Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 53: 717–720

    CAS  Google Scholar 

  • Weh H-J, Wilke H, Dierlamm J, Klaassen U, Siegmund R, Illiger H-J et al. (1994) Weekly therapy with folinic acid and high dose 5-fluorouracil 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. Ann Oncol 5: 233–237

    PubMed  CAS  Google Scholar 

  • Winawer SJ, Zauber AG, Stewart E, O’Brian MJ (1991) The natural history of colorectal cancer: opportunites for intervention. Cancer 67: 1143–1149

    Article  PubMed  CAS  Google Scholar 

  • Wolmark N, Rockette H, Fisher B et al. (1993) The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from national surgical adjuvant breast and bowel project protocol C-03. J Clin Oncol 11: 1879–1887

    PubMed  CAS  Google Scholar 

  • Wolmark N, Rockette H, Mamounas EP et al. (1996) The relative efficacy of 5-FU + leucovorin (FU/LV), 5-FU + levamisole (FU/LEV), and 5-FU + leucovorin +levamisole ( FU-LV-LEV) in patients with Dukes B and C carcinoma of the colon. Proc Am Soc Clin Oncol 15: 460

    Google Scholar 

Download references

Authors
  1. H.-J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmoll, HJ. (1997). Kolorektales Karzinom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation